Literature DB >> 22985477

Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.

Alessandra Handisurya1, Patricia M Day, Cynthia D Thompson, Christopher B Buck, Kihyuck Kwak, Richard B S Roden, Douglas R Lowy, John T Schiller.   

Abstract

Depending upon viral genotype, productive papillomavirus infection and disease display preferential tropism for cutaneous or mucosal stratified squamous epithelia, although the mechanisms are unclear. To investigate papillomavirus entry tropism, we used reporter pseudovirions based on various cutaneous and mucosal papillomavirus species, including the recently identified murine papillomavirus. Pseudovirus transduction of BALB/c mice was examined using an improved murine skin infection protocol and a previously developed cervicovaginal challenge model. In the skin, HPV5, HPV6, HPV16, BPV1 and MusPV1 pseudovirions preferentially transduced keratinocytes at sites of trauma, similar to the genital tract. Skin infection, visualized by in vivo imaging using a luciferase reporter gene, peaked between days 2-3 and rapidly diminished for all pseudovirion types. Murine cutaneous and genital tissues were similarily permissive for pseudovirions of HPV types 5, 6, 8, 16, 18, 26, 44, 45, 51, 58 and animal papillomaviruses BPV1 and MusPV1, implying that papillomavirus' tissue and host tropism is governed primarily by post-entry regulatory events in the mouse. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22985477      PMCID: PMC3552393          DOI: 10.1016/j.virol.2012.08.035

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions.

Authors:  Kazunari Kondo; Yoshiyuki Ishii; Seiichiro Mori; Shiho Shimabukuro; Hiroyuki Yoshikawa; Tadahito Kanda
Journal:  Virology       Date:  2009-09-19       Impact factor: 3.616

2.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.

Authors:  Hans-Ulrich Bernard; Robert D Burk; Zigui Chen; Koenraad van Doorslaer; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

3.  Novel laboratory mouse papillomavirus (MusPV) infection.

Authors:  A Ingle; S Ghim; J Joh; I Chepkoech; A Bennett Jenson; J P Sundberg
Journal:  Vet Pathol       Date:  2010-08-04       Impact factor: 2.221

4.  Diversity of human papillomavirus types in periungual squamous cell carcinoma.

Authors:  A Kreuter; T Gambichler; H Pfister; U Wieland
Journal:  Br J Dermatol       Date:  2009-06-11       Impact factor: 9.302

5.  In vivo mechanisms of vaccine-induced protection against HPV infection.

Authors:  Patricia M Day; Rhonda C Kines; Cynthia D Thompson; Subhashini Jagu; Richard B Roden; Douglas R Lowy; John T Schiller
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

Review 6.  Current understanding of the mechanism of HPV infection.

Authors:  John T Schiller; Patricia M Day; Rhonda C Kines
Journal:  Gynecol Oncol       Date:  2010-06       Impact factor: 5.482

7.  Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Authors:  Katherine M Johnson; Rhonda C Kines; Jeffrey N Roberts; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.

Authors:  Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

9.  Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

Authors:  Hannah H Alphs; Ratish Gambhira; Balasubramanyam Karanam; Jeffrey N Roberts; Subhashini Jagu; John T Schiller; Weiguang Zeng; David C Jackson; Richard B S Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

10.  Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism.

Authors:  Nitesh Mistry; Carl Wibom; Magnus Evander
Journal:  Virol J       Date:  2008-10-14       Impact factor: 4.099

View more
  26 in total

1.  Human papillomavirus capsids preferentially bind and infect tumor cells.

Authors:  Rhonda C Kines; Rebecca J Cerio; Jeffrey N Roberts; Cynthia D Thompson; Elisabet de Los Pinos; Douglas R Lowy; John T Schiller
Journal:  Int J Cancer       Date:  2015-10-27       Impact factor: 7.396

2.  Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.

Authors:  Talía Malagón; Karolina Louvanto; Michel Wissing; Ann N Burchell; Pierre-Paul Tellier; Mariam El-Zein; François Coutlée; Eduardo L Franco
Journal:  Lancet Infect Dis       Date:  2019-02-10       Impact factor: 25.071

3.  Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.

Authors:  Maxime J J Fleury; Antoine Touzé; Pierre Coursaget
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

4.  Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.

Authors:  Diane M Da Silva; Carly A Movius; Adam B Raff; Heike E Brand; Joseph G Skeate; Michael K Wong; W Martin Kast
Journal:  Virology       Date:  2014-02-17       Impact factor: 3.616

5.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

6.  The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane.

Authors:  Patricia M Day; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2015-03-12       Impact factor: 3.616

7.  Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies.

Authors:  Joshua W Wang; Ken Matsui; Yuanji Pan; Kihyuck Kwak; Shiwen Peng; Troy Kemp; Ligia Pinto; Richard B S Roden
Journal:  Curr Protoc Microbiol       Date:  2015-08-03

8.  Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus.

Authors:  Joshua W Wang; Wai Hong Wu; Tsui-Chin Huang; Margaret Wong; Kihyuck Kwak; Keiko Ozato; Chien-Fu Hung; Richard B S Roden
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 9.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

10.  Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization.

Authors:  Alessandra Handisurya; Patricia M Day; Cynthia D Thompson; Christopher B Buck; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.